During this year's event, Siemens will be offering visitors to the congress an extensive theoretical and practical training program on new diagnostic and therapeutic techniques.
The great progress made in medicine during the past few decades has reduced the death rate for cardiac diseases considerably. At the same time, the number of patients with chronic heart diseases such as cardiac insufficiency has been rising, thus increasing healthcare costs. Medical innovations must therefore contribute to cost reduction while at the same time offering a higher quality of health care. In fact, the spectrum of new diagnostic and therapeutic techniques which improve care and can be performed faster as well as in a more patient-friendly manner, has been expanding rapidly.
Innovative methods such as interventional valve therapy require an interdisciplinary collaboration and an integration of techniques from different medical fields. Hybrid operating rooms are just one result of this development. The hybrid OR combines a full-functional cardiac cath lab with a fully equipped operating room. Multidisciplinary teams with cardiologists and cardiac surgeons can thus join forces to perform new types of therapies. Cardiac MR (magnetic resonance tomography) and cardiac CT (computed tomography) offer entirely new insights into the heart, thus providing information on the heart which alters the treatment path for many diseases considerably. These imaging techniques, but also echocardiography and nuclear medicine increasingly enable physicians to offer a more personalized medicine, i.e. to select "the right therapy for the right patient". Furthermore, as so-called "gatekeepers", they help to determine whether cost-intensive therapies such as e.g. the implantation of an ICD (implantable cardioverter/defibrillator) are indicated according to current guidelines.
Such an innovative environment also makes it necessary for physicians to undergo continuing education and training. Siemens Healthcare supports its customers in this regard, and is therefore offering extensive training sessions dealing with innovative techniques in cardiology at this years Congress of the European Society of Cardiology. The topics covered include, for example, cardiovascular CT and MRI, real-time 3D echocardiography and management of heart failure.
Innovation at the ESCSyngo DynaCT Cardiac: 3D imaging in the cathlab
Additional highlights presented at the ESCChange of paradigms in echocardiography: Transthoracic real-time 3D echocardiography within a single heartbeat
With the Acuson SC2000 volume echocardiography system, Siemens showcases the world's first system capable of generating real-time 3D images of the entire heart during a single heartbeat without the need for stitching small cardiac volumes acquired during several heart cycles. This new technology – "echo in a heartbeat" – is one of the greatest innovations in echocardiography since decades. 55 years after echocardiography pioneers Inge Edler and Hellmuth Hertz used Siemens equipment to acquire the first ultrasound images of the heart, real-time 3D echocardiography is now ripe for clinical routine. Due to a completely new transducer technology and an improved system architecture of the Acuson SC2000, the physician obtains an excellent 4D image of the heart, even faster than before, since the system offers automated analysis of the acquired data sets.Coronary CT angiography: highest diagnostic accuracy at an extremely low dose
In the meantime, several clinical studies have confirmed that the Somatom Definition Flash enables cardiac CT with a dose of less than one mSv in over 70 percent of all patients. For example, Stephan Achenbach, Professor of Cardiology at Erlangen-Nuremberg University, reported at this years SCCT congress that he was able to scan the entire heart in 270 milliseconds (ms) with a dose of approx. 0.95 mSv during routine examinations.1Dual energy CT of the heart: Additional information on cardiac perfusion
The current clinical standard for examining myocardial perfusion is SPECT (Single photon emission computed tomography). In a study recently published in the American Journal of Cardiology, myocardial perfusion following an infarct was measured using SPECT, the standard technique as well as dual energy computed tomography (DECT). It showed that DECT correctly identified 96 percent of the permanent myocardial perfusion defects and 88 percent of the reversible myocardial perfusion defects identified with SPECT. DECT compared very well in comparison with SPECT and holds great promise for evaluation of myocardial perfusion.1Magnetic resonance: New functionalities for routine cardiological examinations
With syngo Dynamics 8.0, the corresponding application for remote image viewing will take on a new appearance. The screen display (Look & Feel) and functional sequences will be adapted to the standard workplace. The application offers a high level of performance so treating physicians will be able to conveniently access patient images from almost any location, even at a low network bandwidth.Laboratory diagnostics in cardiology: Troponin test fulfills the most stringent guidelines of cardiology societies
Today, cardiac troponins are the preferred blood markers for diagnosing myocardial infarction. Siemens was the first company to develop a fully automatic, high-precision and highly sensitive troponin test ("TnI Ultra"), which fulfilled the stringent requirements of the ESC and ACC (European Society of Cardiology/American College of Cardiology). Siemens’ TnI Ultra enables an earlier and better identification of infarct patients. Since this troponin test has already been successfully used on the fully automatic "Advia Centaur" immunoassay systems from Siemens Healthcare, it is now also available for the new, integrated Dimension EXL analysis system from Siemens Healthcare.
Dimension EXL provides both clinical chemical and immunodiagnostic parameters on a single platform. This integrated architecture enables parallel processing of the corresponding assays, thus increasing laboratory productivity. In addition to routine and special diagnostics, the parameter menu also includes therapeutic medication monitoring from immune suppressives to drug screening. Using the LOCI (luminescent oxygen channeling immunoassay) module, innovative chemoluminescence technology can be used to supply highly sensitive analysis results in an especially short time.Fast diagnosis of heart failure: NT-proBNP/BNP test
1 Achenbach et al. Sub-mSv Coronary CT Angiography Using Prospectively ECG-Triggered High-Pitch Spiral Acquisition, SCCT 2009 proceedings, 17.07.09
2 Ruzsics B et al. Comparison of dual-energy computed tomography of the heart with single photon emission computed tomography for assessment of coronary artery stenosis and of the myocardial blood supply. Am J Cardiol. 2009 Aug 1;104(3):318-26.
The Siemens Healthcare Sector is one of the largest suppliers of healthcare technology worldwide. The company is a medical solution provider with core competences and innovative strengths in diagnostic and therapeutic technologies as well as knowledge processing, including information technology and system integration. With its acquisitions in laboratory diagnostics, Siemens Healthcare is the first integrated healthcare company that combines imaging and lab diagnostics, therapy solutions and medical information technology and also supplements these with consultation and services. Siemens Healthcare offers solutions for the entire supply chain under one roof - from prevention and early detection to diagnosis and to treatment and aftercare. In addition, Siemens Healthcare is the global brand leader for innovative hearing aids. Siemens Healthcare currently has around 49,000 employees worldwide and is represented in more than 130 countries. During fiscal 2008 (ending on September 30), Siemens Healthcare achieved a total sales volume of € 11.17 billion and incoming orders totaling € 11.78 billion. The Group earnings amounted to € 1.23 billion.
Bianca Braun | Siemens Healthcare
Further reports about: > 3D images > Acuson S2000 ABVS > Acuson SC2000 > BNP > CMR > Cardiology > DECT > DynaCT > Dynamic > ESC > EXL > Healthcare > IQ•SPECT > NT-proBNP/BNP > SC2000 > SCCT > SPECT > Somatom > cardiac > computed tomography > diagnostic accuracy > heart disease > heart failure > imaging techniques > information technology > magnetic resonance > magnetic resonance tomograph > single photon > single photon emission computed tomography > syngo Dynamics
New Process Technology Unlocks Boost in Laser Productivity
18.05.2017 | Fraunhofer-Institut für Lasertechnik ILT
OLED microdisplays as high-precision optical fingerprint sensors
09.05.2017 | Fraunhofer-Institut für Organische Elektronik, Elektronenstrahl- und Plasmatechnik FEP
Scientists have developed a new method of characterizing graphene’s properties without applying disruptive electrical contacts, allowing them to investigate both the resistance and quantum capacitance of graphene and other two-dimensional materials. Researchers from the Swiss Nanoscience Institute and the University of Basel’s Department of Physics reported their findings in the journal Physical Review Applied.
Graphene consists of a single layer of carbon atoms. It is transparent, harder than diamond and stronger than steel, yet flexible, and a significantly better...
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
30.05.2017 | Life Sciences
30.05.2017 | Life Sciences
30.05.2017 | Physics and Astronomy